Clinical Trials on Adrenal Hyperplasia

Total 15331 results

GlaxoSmithKline

Completed

Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement (CONDUCT)

Prostatic Hyperplasia

Italy, Spain, United Kingdom, Netherlands, Greece, Romania, France, Germany
GlaxoSmithKline

Completed

Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects

Prostatic Hyperplasia

United States
GlaxoSmithKline

Completed

Bioequivalence Study of Dutasteride Capsules in Healthy Japanese Male Subjects

Prostatic Hyperplasia

Japan
GlaxoSmithKline

Completed

Bioequivalence - Duodart Against Avodart & Omnic

Prostatic Hyperplasia

Russian Federation
Kayseri Education and Research Hospital

Unknown

Irisin Hormone Levels in Endometrial Hyperplasia

Endometrial Hyperplasia

Turkey
Milton S. Hershey Medical Center
Center for Research on Women and Health

Terminated

Ultrasound and Endometrial Hyperplasia

Endometrial Hyperplasia

United States
Boehringer Ingelheim

Completed

FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Observational Study of ALNA® (Tamsulosin) in Patients With Benign Prostatic Hyperplasia (BPH)

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Safety Profile of Secotex ® in Patients With Benign Prostatic Hyperplasia

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia

Prostatic Hyperplasia
Seoul National University Hospital

Unknown

Storage Symptom After Laser Prostatectomy

Prostatic Hyperplasia

Korea, Republic of
Korean Gynecologic Oncology Group

Unknown

Management of Endometrial Hyperplasia With a LNG-IUS: Multicenter Study: KGOG2006 (KGOG2006)

Endometrial Hyperplasia

Korea, Republic of
Mansoura University

Completed

Efficacy of LNG-IUS for Treatment of Non-atypical Endometrial Hyperplasia in Perimenopausal Women

Endometrial Hyperplasia

Egypt
Sanofi

Completed

Benign Prostatic Hyperplasia in Taiwan

Prostatic Diseases

Taiwan
Sanofi

Completed

SAMBA: Sexuality And Management of Benign Prostatic Hyperplasia With Alfuzosin

Prostatic Hyperplasia

Colombia, Mexico, Ecuador, Guatemala
Mansoura University

Recruiting

Green LEP vs ThuLEP in Management of Marked Enlarged Prostate

Prostatic Hyperplasia With Urinary Obstruction

Egypt
Spectrum Pharmaceuticals, Inc

Terminated

Trial of the Safety and Efficacy of Ozarelix in Participants With Benign Prostatic Hyperplasia (BPH)

Benign Prostatic Hyperplasia (BPH) | Lower Urinary Tract Symptoms (LUTS)

United States
Fundacion Miguel Servet

Completed

Clinical Trial to Evaluate the Efficacy and Safety of the Transarterial Supraselective Embolization of the Prostate to Treat the Urinary Symptoms.

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia | Transurethral Resection of Prostate | Artery Embolization

Spain
Moscow State University of Medicine and Dentistry

Recruiting

Intermittent Catheterization Versus Trial Without Catheter

Benign Prostatic Hyperplasia

Russian Federation
GlaxoSmithKline

Terminated

Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter

Benign Prostatic Hyperplasia

United Kingdom
Manchanda Medical Clinic

Not yet recruiting

Prostatic Hyperplasia Treatment and Cancer Prevention

Prostatic Hyperplasia
Ziauddin University

Completed

Cementation Techniques; an In-vitro Study

Dental Cements | Tooth Crown Fracture | Cementation Teeth; Hyperplasia

Pakistan
GlaxoSmithKline

Completed

Benign Prostatic Hyperplasia (BPH) Screening Tool Case Finding Study in Subjects >=50 Years

Prostatic Hyperplasia

Germany, Russian Federation, Spain, Italy, France
Ain Shams University

Completed

HoLEP vs mTURP in Management of Benign Prostatic Hyperplasia

Prostatic Hyperplasia

Egypt
Boehringer Ingelheim

Completed

Determine the Bioequivalence of Two Formulations of Tamsulosin HCl Capsules in Fasted Male.

Prostatic Hyperplasia
Marmara University

Unknown

Benign Prostatic Hyperplasia and Glycosaminoglycan

Prostatic Hyperplasia

Turkey
University Hospital of North Norway
Norwegian Cancer Society; Helse Nord

Completed

A Study Comparing Mirena and Systemic Progestin for Endometrial Hyperplasia (Mirena)

Endometrial Hyperplasia

Norway
GlaxoSmithKline

Completed

Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects

Prostatic Hyperplasia

Japan
GlaxoSmithKline

Terminated

Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia (FDC114785)

Prostatic Hyperplasia

Vietnam
GlaxoSmithKline

Completed

Prospective Sexual Function Study for BPH Subjects

Prostatic Hyperplasia

Germany, Australia, Netherlands, Spain, Hungary, France, Greece
John D Louie

Withdrawn

Prostate Artery Embolization for the Treatment of Benign Prostatic Hyperplasia

Prostatic Hyperplasia

United States
GlaxoSmithKline

Completed

Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASIS

Prostatic Hyperplasia

United Kingdom
GlaxoSmithKline

Completed

A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State

Prostatic Hyperplasia

United States
GlaxoSmithKline

Completed

Establishing Predictors of Enlarged Prostate Treatment Adherence: Linking Symptom Improvement to Adherence

Prostatic Hyperplasia
GlaxoSmithKline

Completed

Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment

Prostatic Hyperplasia

United States, Netherlands, Spain, Taiwan, Bulgaria, Estonia, Hungary, Italy, Belgium, Thailand, Israel, Germany, Canada, Korea, Republic of, Norway, Finland, Russian Federation, Romania, Brazil, France, Slovakia, Philippines, South... and more
GlaxoSmithKline

Completed

Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels

Prostatic Hyperplasia

United States
Boehringer Ingelheim

Completed

Observational Study in Patients With Functional Benign Prostatic Hyperplasia Symptoms Who Switched From Phytotherapy to ALNA® (Tamsulosin)

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Prescription Event Monitoring in Patients With Benign Prostatic Hyperplasia (BPH)

Prostatic Hyperplasia
Boehringer Ingelheim

Completed

Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia

Prostatic Hyperplasia
Medical University of Vienna

Completed

Women With Asymptomatic Endometrial Hyperplasia (FAME-ENDO)

Endometrial Hyperplasia

Austria
Sanofi

Completed

Efficacy and Safety of SL77.0499-10 (Alfuzosin) Versus Placebo and Tamsulosin in Japanese Patients With Benign Prostatic Hyperplasia

Prostatic Hyperplasia

Japan
University of Messina

Completed

Genistein and Endometrial Hyperplasia

Endometrial Hyperplasia

Italy
Milkhaus Laboratory

Unknown

A 20-Week Study of a New Treatment for Men With Benign Prostatic Hyperplasia (BPH).

Prostatic Hyperplasia

United States
Turku University Hospital
University of Turku

Recruiting

Prostate Metabolism, Cancer Risk and Gut Microbiota (PROMIC)

Prostate Cancer | Prostate Hyperplasia

Finland
Mansoura University

Recruiting

The Learning Curve of Transurethral Holmium Laser Enucleation of the Prostate, Prospective Assessment

Learning Curve | Prostate Hyperplasia | Laser

Egypt
Mansoura University

Unknown

Ejaculatory Sparing Transurethral Incision Of The Prostate (ES-TUIP) Versus Conventional TUIP

Prostate Hyperplasia | Transurethral Incision Of The Prostate | Ejaculatory Dysfunction

Egypt
Peking University Third Hospital

Completed

Application of DWI in Diagnosis of Prostate Cancer

Benign Prostatic Hyperplasia | Prostate Cancer
Rennes University Hospital

Completed

Evaluation of the Potential Association Between 5α-reductase Inhibitors Prescription and Occurrence of High Grade Prostate Cancers (CANARI)

Benign Prostate Hyperplasia

France
GlaxoSmithKline

Completed

Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer

Benign Prostatic Hyperplasia | Prostate Cancer

Netherlands
GL Pharm Tech Corporation

Completed

Study to Investigate the Efficacy and Safety of GL2702 GLARS-NF1tablet and Harnal-D - Tablet in BPH Patients With LUTS (GL2702)

Benign Prostatic Hyperplasia

Korea, Republic of

3

Subscribe